FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds of the formula (I) 
and their pharmaceutically acceptable salts and esters. In the general formula (I) X means oxygen (O) or sulfur (S) atom; R means hydrogen atom (H) or (C1-C6)-alkyl; R1 means H, -COOR, (C3-C8)-cycloalkyl or (C1-C6)-alkyl, (C2-C6)-alkenyl or (C1-C6)-alkoxyl and each of them can be unsubstituted or comprises substitutes; values of radicals R2, R3, R4, R5 and R6 are given in the invention claim. Also, invention relates to a pharmaceutical composition based on compounds of the general formula (I) and to intermediate compounds of the general formula (II) 
and the general formula (III) 
that are used for synthesis of derivatives of indane acetic acid. Proposed compounds effect on the blood glucose level and serum triglycerides level and can be used in treatment of such diseases as diabetes mellitus, obesity, hyperlipidemia and atherosclerosis.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
28 cl, 6 tbl, 6 sch, 251 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
| COMPOUNDS USEFUL AS TRPM8 MODULATORS | 2011 |
|
RU2608109C2 |
| NOVEL COMPOUNDS OF CONDENSED HETEROCYCLYL-CARBOHYDRAZONOYL DICYANIDES AND USE THEREOF | 2021 |
|
RU2826002C1 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
| 2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3,5]NONANE DERIVATIVES AND USE THEREOF AS GHRELIN RECEPTOR ANTAGONISTS OR INVERSE AGONISTS | 2011 |
|
RU2524341C2 |
| 2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
| BENZOTHIAZINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAL DRUGS | 2010 |
|
RU2523791C2 |
| SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PREPARING (VARIANTS) AND USING AS AGENTS AGAINST OBESITY AND HYPERHOLESTEROLEMIA | 2000 |
|
RU2278114C2 |
| OXAZOLE DERIVATIVES SUBSTITUTED WITH CARBOXYLIC ACIDS AS PPAR-ALPHA AND PPAR-GAMMA ACTIVATORS IN DIABETES TREATMENT | 2002 |
|
RU2278859C2 |
| PYRROLOPYRIMIDINE COMPOUNDS FOR MALIGNANT TUMOUR TREATMENT | 2012 |
|
RU2631655C2 |
